144 - May 17, 2023 | SEC Filings

Brief

Rocket Lab USA Director Michael D. Griffin filed Form 144 on May 17, 2023, to sell 50,689 shares of common stock acquired via restricted stock vesting on March 1, 2023, as compensation. The aggregate market value is $223,031.60, with no sales reported in the prior three months. This routine disclosure ensures transparency for insider transactions under Rule 144.

Detailed Brief

Form 144 filing discloses Director Michael D. Griffin's intent to sell 50,689 shares of Rocket Lab USA Inc. (RKLB) common stock through Fidelity Brokerage Services. The shares, representing vested restricted stock units issued as compensation on March 1, 2023, have an aggregate market value of $223,031.60 based on the filing date, implying a price around $4.40 per share. Approximately 478.7 million shares are outstanding. No securities were sold by Griffin in the past three months, and the sale occurs via a Logiq Inc. account where he is a stakeholder. The filing includes the required representation of no undisclosed material adverse information. This is standard for insiders selling restricted securities under Rule 144, common in compensation plans for space industry executives like Griffin, former NASA administrator.

Key Telemetry

• Director Michael D. Griffin to sell 50,689 common shares (value $223,031.60) on ~05/17/2023.

• Shares from RSU vesting on 03/01/2023 as compensation from issuer.

• No sales by Griffin in past 3 months.

• Outstanding shares: 478,661,458; negligible dilution impact.

• Filed via Fidelity; routine Rule 144 notice.

Impact Vector

Minimal near-term impact for RKLB investors as the sale represents ~0.01% of outstanding shares and stems from routine vesting of compensation equity, not open-market distress selling. Signals director liquidity needs but no adverse info disclosed. Strategic significance low; monitor for patterns in insider sales or 10b5-1 plans amid Rocket Lab's growth in launches and Neutron rocket development.